The largest database of trusted experimental protocols

Human cytokine 30 plex panel

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Human cytokine 30-plex panel is a multiplex assay designed to simultaneously measure the concentrations of 30 different human cytokines and chemokines in a single sample. The panel allows for the quantitative analysis of multiple analytes from a small sample volume.

Automatically generated - may contain errors

18 protocols using human cytokine 30 plex panel

1

Serum and Wound Effluent Protein Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum and wound effluent proteins were quantified using a Luminex 100/200 IS xMAP Bead Array Platform (Millipore Corp, Billerica, MA) as previously described (Hawksworth et al., 2009 (link)). Thirty-two cytokines, chemokines and growth factors were quantified using a Human Cytokine 30-plex panel supplemented with a custom Human 2-plex panel (Life Technologies; Cat. No LHC6003 and LCP0002, Grand Island, NY). Data were categorized as related to the initial débridement, the penultimate débridement, and the final débridement.
+ Open protocol
+ Expand
2

Cytokine Profiling of MSC-PBMC Coculture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Supernatants were collected from fit and senescent MSCs cocultured with activated PBMCs for 4 days and stored at −80 °C. Thawed supernatants were centrifuged at 1500 rpm for 3 minutes to eliminate cell debris and analyzed by magnetic bead–based multiplex luminex assays for cytokines, chemokines, and certain growth factors (supplemental Figures 1 and 3) (human cytokine 30-plex panel, Life Technologies) according to the manufacturer’s instructions using Luminex xMAP (multi-analyte profiling) technology. Kynurenine enzyme-linked immunosorbent assay was performed as described in the manufacturer’s instructions (US Biological Sciences).
+ Open protocol
+ Expand
3

Co-culture of Calu-3 Cells and PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the co-culture studies, calu-3 cells were seeded and infected with 0.05 MOI of infectious virus and mock-infected cell control material in duplicate wells. The inoculum was removed 2 hours later and 500 µl of calu-3 media was added to each well. The media was removed and fresh media was added one day post infection (p.i.). One day later, i.e. 2 days p.i., trans-well inserts (polyester trans-well inserts, 0.33 cm with 0.4 u pores, Corning, Inc., Corning, NY) with one million live PBMCs (viability determined by trypan blue exclusion) were placed in the virus infected and control wells. Media was collected from the basolateral chamber at 6, 24, and 48 hours after addition of the PBMCs. The collected media was centrifuged, stored at −80°C, and later tested by multiplex luminex assays according to the manufacturer's instructions for FGF-Basic, IFN-γ, IL–12 (p40 / p70), IL–13, RANTES, MIP–1α, MIG, MIP–1β, VEGF, IL–1β, IL–2, IL–4, IL–5, IL–6, IL–2R, MCP–1, Eotaxin, IL–8, IL–10, IL–15, IL–17, IL–1RA, GM–CSF, G–CSF, EGF, HGF, TNF-α, IL–7, IP-10, IFN-α (Human cytokine 30-plex panel, Life technologies) and ENA-78, MCP-2 and IL-28A (Human cytokine 3 plex panel, Millipore).
+ Open protocol
+ Expand
4

Multiplex Cytokine Profiling of Supernatants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Multiplex luminex assays were performed from the collected supernatant according to the manufacturer’s instructions for IFN–γ, IL–12 (p40/p70) IL–13, RANTES, MIP–1α, MIG, MIP– 1β, IL–1β, IL–2, IL–4, IL–5, IL–6, IL–2R, MCP–1, Eotaxin, IL–8, IL–10, IL–15, IL–17, IL– 1RA, GM–CSF,, TNF–α, IL–7, IP–10, IFN–α (Human cytokine 30-plex panel, Life technologies) using Luminex × MAP technology.
+ Open protocol
+ Expand
5

Multiplex Cytokine Profiling of Cryopreserved Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved (−80°C) samples were analyzed using Human cytokine 30-plex panel (Life Technologies, Carlsbad, CA) and FlexMAP 3D instrument (Luminex, Austin, TX). Data analysis was done using xPONENT software (Luminex).
+ Open protocol
+ Expand
6

Multiplex Cytokine Profiling of Cell Supernatants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Supernatants from co-culture of MSCs and/or PBMCs were collected after 4 days and stored at −80°C. Stored supernatants were thawed and centrifuged at 500 × g for 3 min to eliminate cell debris and analyzed by magnetic bead-based multiplex luminex assays for cytokines, chemokines, and growth factors, including FGF-basic, IFN-γ, IL-12(p40/p70), IL-13, CCL5(regulated on activation, normal T cell expressed and secreted or CCL5 [RANTES]), CCL3(MIP-1α), CXCL9(monokine induced by gamma interferon or CXCL9 [MIG]), CCL4(MIP-1β), VEGF, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-2R, CCL2(MCP-1), CCL11(Eotaxin), IL-8, IL-10, IL-15, IL-17, IL-1RA, granulocyte-macrophage colony-stimulating factor [GM-CSF], granulocyte-colony stimulating factor (G-CSF), epidermal growth factor (EGF), HGF, TNF-α, IL-7, CXCL10(IP-10), and IFN-α (Human Cytokine 30-plex Panel, Life Technologies), according to the manufacturer’s instructions using luminex xMAP (multi-analyte profiling) technology. Results were plotted as picograms per milliliter.
+ Open protocol
+ Expand
7

Secretome Analysis of Organoid Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
The used medium from the organoid culture was analyzed for secretome diversity and levels. Supernatants of conditioned organoid media were collected 3 days after a fresh medium change, followed by a brief centrifugation (500g for 5 minutes) and then stored at –80°C. Subsequently, medium supernatants were analyzed by magnetic bead-based multiplex Luminex assays for cytokines, chemokines, and growth factors, including fibroblast growth factor-basic, interferon-γ, IL12 (p40/p70), IL13, CCL5 (regulated on activation, normal T-cell expressed and secreted or CCL5 [RANTES]), CCL3 (MIP-1alpha), CXCL9 (monokine induced by gamma interferon or CXCL9 [MIG]), CCL4 (MIP-1beta), VEGF, IL1b, IL2, IL4, IL5, IL6, IL2R, CCL2 (MCP-1), CCL11 (Eotaxin), IL8, IL10, IL15, IL17, IL1RA, granulocyte-macrophage colony-stimulating factor, granulocyte-colony stimulating factor, epidermal growth factor, HGF, tumor necrosis factor alpha, IL7, CXCL10 (IP-10), and interferon-α (Human Cytokine 30-plex Panel; Life Technologies, Carlsbad, CA), according to the manufacturer’s instructions using Luminex xMAP (multi-analyte profiling) technology. Results were plotted as picograms per milliliter.
+ Open protocol
+ Expand
8

Multiplex Cytokine Analysis in Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used multiplex cytokine kits (Invitrogen Human Cytokine 30-Plex Panel, LHC6003) in order to measure serum levels of IL-1β, IL-5, IL-6, IL-7, IL-12, and TNF-α. Dose measurements were performed with the use of a Luminex 200 system (Luminex Corporation, Austin, TX, USA) in accordance with the manufacturer's specifications (Invitrogen Corporation, Carlsbad, CA, USA). The sensitivity of the test was specified by the manufacturer (Invitrogen Corporation, Carlsbad, CA, USA) in the informative material included in the kits.
The average sensitivity of the test for IL-1β was 5 pg/ ml, with an inter-assay variation coefficient of 4.8%. For IL-5, the average sensitivity of the test was 0.5 pg/ml with an inter-assay variation coefficient of 7.5%. The average sensitivity of the test for IL-6 was 0.5 pg/ml with an inter-assay variation coefficient of 7%. In the case of IL-7, the average sensitivity of the test was 10 pg/ml with an inter-assay variation coefficient of 9.8%. The sensitivity of the test for IL-12 was 1 pg/ml, and the inter-assay variation coefficient of 8.1%. The test for TNF-α revealed an average sensitivity of 0.5 pg/ml, with inter-assay variation coefficient of 8.3%.
+ Open protocol
+ Expand
9

Multiplex Plasma Cytokine Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood samples were taken by venous puncture and collected in sterile EDTA Vacutainers, between 8:00 and 10:00 a.m., they were processed immediately or within 2 hours after extraction. Plasma samples were obtained after high speed centrifugation for 10 minutes at 3,500–4,000 rpm and immediately aliquoted and frozen at -80°C for its conservation.
Plasma samples were clarified by high-speed centrifugation and analyzed using Luminex xMAP technology platform. The current investigation required the assembly of an extensive multiplex array consisting of cytokines, chemokines, soluble receptors, growth and angiogenic factors, which were evaluated using bead-based immunoassays. The selected array was the Human cytokine 30-Plex panel (Invitrogen) with the following analytes: IL-1β, IL-1RA, IL-2, IL-2R, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, IL-15, IL-17, TNF-α, IFN-α, IFN-γ, GM-CSF, MIP-1α, MIP-1β/CCL4, IP-10, MIG, Eotaxin/CCL11, Rantes/CCL5, MCP-1/CCL2, VEGF, G-CSF, EGF, FGF-basic, and HGF.
+ Open protocol
+ Expand
10

Multiplex Cytokine Profiling of Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used multiplex cytokine kits (Invitrogen Human Cytokine 30-Plex Panel, LHC6003) in order to measure serum levels of IL-4. Measurements were performed with a Luminex 200 system (Luminex Corporation, Austin, TX, USA) in accordance with the manufacturer's specifications (Invitrogen Corporation, Carlsbad, CA, USA). The sensitivity of the test was specified by the manufacturer (Invitrogen Corporation, Carlsbad, CA, USA). The average sensitivity of the test was < 0.5 pg/ml, with an inter-assay variation coefficient of 8.7%.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!